FDA Adverse Event Malfunction Summary report: N

BD VEO¿ INSULIN SYRINGE WITH THE BD ULTRA-FINE¿ NEEDLE

MDR report key: 15818852 · Received November 17, 2022

Report

Report Number
1920898-2022-00812
Event Type
Malfunction
Date Received
November 17, 2022
Date of Event
October 26, 2022
Report Date
January 12, 2023
Manufacturer
BD MEDICAL - DIABETES CARE
Product Code
FMF
UDI-DI
00382904910013
PMA / PMN Number
K212499
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D10: DEVICE AVAILABLE FOR EVAL YES AND D10: RETURNED TO MANUFACTURER ON: 03-NOV-2022. INVESTIGATION SUMMARY: CUSTOMER RETURNED (50) SYRINGE SAMPLES FROM LOT# 1242719, (4) SYRINGE SAMPLES FROM LOT# 1347417, AND (31) SYRINGE SAMPLES FROM LOT# 1214676. ALL RETURNED SYRINGES WERE EXAMINED, AND IT WAS OBSERVED THAT A CLEAR LIQUID CAME OUT OF THE CANNULA FROM 1 OF THE SYRINGES FROM EACH RETURNED LOT. A SMALL PORTION OF THE LIQUID WAS REMOVED THEN PREPARED FOR FTIR SPECTRAL ANALYSIS. THE SPECTRAL ANALYSIS SUGGESTS THAT THIS MATERIAL HAS COMPONENTS SIMILAR TO THOSE OF SILICONE. SAMPLES FROM EACH LOT WERE FORWARDED TO MANUFACTURING (HOLDREGE) FOR FURTHER INVESTIGATION. A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED FOR BATCH#S 1347417, 1242719, 1214676. ALL INSPECTIONS AND CHALLENGES WERE PERFORMED PER THE APPLICABLE OPERATIONS QC SPECIFICATIONS.

Additional Manufacturer Narrative · 0

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH LOT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 1347417 MEDICAL DEVICE EXPIRATION DATE: 31-DEC-2026 DEVICE MANUFACTURE DATE: 13-DEC-2021. MEDICAL DEVICE LOT #: 1242719 MEDICAL DEVICE EXPIRATION DATE: 30-SEP-2026 DEVICE MANUFACTURE DATE: 30-AUG-2021. MEDICAL DEVICE LOT #: 1214676 MEDICAL DEVICE EXPIRATION DATE: 31-AUG-2026 DEVICE MANUFACTURE DATE: 02-AUG-2021. INITIAL REPORTER PHONE#: UNKNOWN. INITIAL REPORTER E-MAIL: UNKNOWN. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED THAT 1 BD VEO¿ INSULIN SYRINGE WITH THE BD ULTRA-FINE¿ NEEDLE EACH FROM LOTS 1347417, 1242719, AND 1214676 HAD EXCESSIVE LUBRICANT ON THEM. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE CUSTOMER STATED THAT THERE WAS SAME PROBLEM(EXCESSIVE LUBRICANT) IN THE COMPENSATION SAMPLES. THE LOT# IS 1347417. ALSO THE CUSTOMER SENT ANOTHER LOT#(1242719) SYRINGES WITH THE SAME PROBLEM(EXCESSIVE LUBRICANT)."

Description of Event or Problem · 0

IT WAS REPORTED THAT 1 BD VEO¿ INSULIN SYRINGE WITH THE BD ULTRA-FINE¿ NEEDLE EACH FROM LOTS 1347417, 1242719, AND 1214676 HAD EXCESSIVE LUBRICANT ON THEM. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE CUSTOMER STATED THAT THERE WAS SAME PROBLEM(EXCESSIVE LUBRICANT) IN THE COMPENSATION SAMPLES. THE LOT# IS 1347417. ALSO THE CUSTOMER SENT ANOTHER LOT# (1242719) SYRINGES WITH THE SAME PROBLEM(EXCESSIVE LUBRICANT)."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
212173 BD VEO¿ INSULIN SYRINGE WITH THE BD ULTRA-FINE¿ NEEDLE PISTON SYRINGE FMF BD MEDICAL - DIABETES CARE SEE H10 00382904910013

Patients

Seq Age Sex Outcome Treatment
1 Unknown